Burning Rock Biotech Net Common Equity Issued/Repurchased 2021-2024 | BNR
Burning Rock Biotech Annual Net Common Equity Issued/Repurchased (Millions of US $) |
|
---|---|
2024 | $0 |
2023 | $-1 |
2022 | $-10 |
2021 | $-1 |
2020 | $294 |
2019 | $N/A |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Business Services | Technology Services | $0.029B | $0.071B |
Burning Rock Biotech Limited focuses on the application of next generation sequencing technology in the field of precision oncology. Its business consists of NGS-based therapy selection testing for late-stage cancer patients as well as NGS-based cancer early detection. Burning Rock Biotech Limited is based in GUANGZHOU, China. |